PRIMARY OBJECTIVE:~I. To assess change in patient knowledge about tumor next generation sequencing (NGS) following exposure to the video.~SECONDARY OBJECTIVES:~I.To assess changes following exposure to the video, including; Ia. Genomic knowledge via the validated 10 true/false question survey (% correct out of 10).~Ib. 11-item Trust in Physician Survey (TPS) as a single TPS score. Ic. Comparison of results in three patient cohorts: 1) Metastatic breast cancer; 2) lung cancer; 3) metastatic cancer of unspecified type.~EXPLORATORY OBJECTIVE:~I. Assess whether therapies prescribed as a result of tumor NGS achieved clinically favorable result through chart review.~OUTLINE:~Patients participate in a video intervention session and complete questionnaires at baseline, after participating in the video intervention, and after receiving NGS results.
This clinical trial tests whether a video intervention improves patient understanding of tumor genomic testing in patients with cancer that has spread to other parts of the body (metastatic). Measuring how the video intervention affects patient understanding of tumor genomic testing in patients with metastatic cancer may help doctors provide patient-centered care by effectively communicating the importance of tumor genomic testing.